Studies in liver cancer have shown that elevated hypoxia-inducible factor-1α (HIF-1α) levels after TACE can promote angiogenesis, which may facilitate tumor metastasis/recurrence and potentially induce radioresistance (20). This evidence concerns the gene HIF1A and liver cancer.